Poolbeg Pharma Plc
Confirmation that the licence to develop oral vaccine delivery platform has been executed
SPONSORED
By Elric Langton | 31st January 2022
We have previously been told the focus is to get Poolbeg Pharma (AIM: POLB) a clinical-stage infectious disease pharmaceutical company with a capital-light clinical model, into shape and get deals done. True to their word, the BOD has announced a few deals recently, the latest confirming that it has signed tβ¦